Agonist-, Antagonist-, and Benzodiazepine-Induced Structural Changes in the α1 Met113-Leu132 Region of the GABAA Receptor
Authors:
- 1 February 2007
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 71 (2) , 483-493
Abstract
The structural basis by which agonists, antagonists, and allosteric modulators exert their distinct actions on ligand-gated ion channels is poorly understood. We used the substituted cysteine accessibility method to probe the structure of the GABAA receptor in the presence of ligands that elicit different pharmacological effects. Residues in the alpha1 Met113-Leu132 region of the GABA binding site were individually mutated to cysteine and expressed with wild-type beta2 and gamma2 subunits in Xenopus laevis oocytes. Using electrophysiology, we determined the rates of reaction of N-biotinaminoethyl methaneth-iosulfonate (MTSEA-biotin) with the introduced cysteines in the resting (unliganded) state and compared them with rates determined in the presence of GABA (agonist), 4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid hydrobromide (SR-95531; antagonist), pentobarbital (allosteric modulator), and flurazepam (allosteric modulator). alpha1N115C, alpha1L117C, alpha1T129C, and alpha1R131C are predicted to line the GABA binding pocket because MTSEA-biotin modification of these residues decreased the amount of current elicited by GABA, and the rates/extents of modification were decreased both by GABA and SR-95531. Reaction rates of some substituted cysteines were different depending on the ligand, indicating that barbiturate- and GABA-induced channel gating, antagonist binding, and benzodiazepine modulation induce specific structural rearrangements. Chemical reactivity of alpha1E122C was decreased by either GABA or pentobarbital but was unaltered by SR-95531 binding, whereas alpha1L127C reactivity was decreased by agonist and antagonist binding but not affected by pentobarbital. Furthermore, alpha1E122C, alpha1L127C, and alpha1R131C changed accessibility in response to flurazepam, providing structural evidence that residues in and near the GABA binding site move in response to benzodiazepine modulation.Keywords
This publication has 43 references indexed in Scilit:
- Mechanism of action of benzodiazepines on GABA A receptorsBritish Journal of Pharmacology, 2006
- Tyrosine Residues That Control Binding and Gating in the 5-Hydroxytryptamine3Receptor Revealed by Unnatural Amino Acid MutagenesisJournal of Neuroscience, 2004
- Nicotine and Carbamylcholine Binding to Nicotinic Acetylcholine Receptors as Studied in AChBP Crystal StructuresNeuron, 2004
- GABAA Receptor Structure–Function Studies: A Reexamination in Light of New Acetylcholine Receptor Structures2004
- GABAA Receptor β2Tyr97 and Leu99 Line the GABA-binding SiteJournal of Biological Chemistry, 2002
- Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptorsNature, 2001
- Mechanisms for Activation and Antagonism of an AMPA-Sensitive Glutamate ReceptorNeuron, 2000
- Mapping the Agonist Binding Site of the GABAAReceptor: Evidence for a β-StrandJournal of Neuroscience, 1999
- Molecular Dissection of Benzodiazepine Binding and Allosteric Coupling Using Chimeric γ-Aminobutyric AcidA Receptor SubunitsMolecular Pharmacology, 1998
- GABAA receptor needs two homologous domains of the & beta;-subunit for activation by GABA but not by pentobarbitalNature, 1993